Desai & Diwanji is delighted to have advised Ceph Lifesciences Private Limited on its proposed acquisition of the API business of Nectar Lifesciences Limited through a Business Transfer Agreement and certain other assets through an Asset Purchase Agreement, for a total deal value of INR 1290 Crores.
Ceph Lifesciences is an emerging pharmaceutical company with a focus on expanding its footprint in the active pharmaceutical ingredients (API) sector, catering to both domestic and international markets.
The transactional team consisted of Partners Anoj Menon and Mitali Mehta along with Shreya Solenkey, Harshith Iyer, Pulkit Palak, and Anusrita Ranjan.
The due diligence team consisted of Partner Mitali Mehta who was supported by Shreya Solenkey, Harshith Iyer, Pulkit Palak, Shanay Patrawala, Anusrita Ranjan, Henna Vora, and Tanishka Saxena.
The deal reporting on this platform is based on the information received from law firms, and therefore, some details may be missing/incomplete. If your firm has not been credited for this deal, write to us at chanchal.makhija@thegreymatter.co.in mentioning your firm’s name, lawyers involved (including designation) and client represented.
